IHS Chemical Week

Regions :: North America :: U.S.

Invista signs second biobased butadiene development deal

1:31 PM MST | February 6, 2013 | Rebecca Coons

Seattle biocatalysis firm Arzeda says it has entered into a collaboration with Invista to develop a biobased route to a butadiene, a key raw material that is increasingly in short supply. Although still in the early stages of development, Invista tells CW it expects to begin commercializing the technology in 2016. The agreement leverages Invista's existing capabilities in biotechnology and catalysis and Arzeda's synthetic biology and enzyme design expertise. The initial focus of the collaboration will be on the production of biobased butadiene, although the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa